Cargando…

Production of Foot-and-Mouth Disease Type O and A Vaccine Antigens on a Pilot Scale and Determination of Optimal Amount of Antigen for Monovalent Vaccines

Foot-and-mouth disease (FMD) is a highly infectious disease affecting cloven-hoofed animals and causes significant economic losses to the livestock industry. The Type O PanAsia-2 (O PA-2) vaccine strain is protective against a wide range of serotype O FMD virus (FMDV) strains in East Asia, and A22 I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jae Young, Lee, Ji-Hye, Yang, Jong Min, Lee, Seo-Yong, Park, Sun Young, Jin, Jong Sook, Kim, Dohyun, Park, Jung-Won, Park, Jong-Hyeon, Park, Sang Hyun, Ko, Young-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383391/ https://www.ncbi.nlm.nih.gov/pubmed/37514972 http://dx.doi.org/10.3390/vaccines11071156

Ejemplares similares

Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Efficacy of Binary Ethylenimine in the Inactivation of Foot-and-Mouth Disease Virus for Vaccine Production in South Korea
por: Kim, Jae Young, et al.
Publicado: (2023)

Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2022)

Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
por: Kim, Ah-Young, et al.
Publicado: (2021)

Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens
por: Park, Sun Young, et al.
Publicado: (2022)

Development of Monoclonal Antibody to Specifically Recognize VP0 but Not VP4 and VP2 of Foot-and-Mouth Disease Virus
por: Park, Sun Young, et al.
Publicado: (2022)

Efficient Removal of Non-Structural Protein Using Chloroform for Foot-and-Mouth Disease Vaccine Production
por: Park, Sun Young, et al.
Publicado: (2020)

Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain
por: Kim, Rae-Hyung, et al.
Publicado: (2015)

Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses
por: Lee, Seo-Yong, et al.
Publicado: (2017)

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
por: Park, Sang-Hyun, et al.
Publicado: (2021)

Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine
por: Park, Min-Eun, et al.
Publicado: (2017)

Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor
por: Park, Soonyong, et al.
Publicado: (2021)

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A
por: Kim, Dong-Wan, et al.
Publicado: (2023)

Requirements for improved vaccines against foot-and-mouth disease epidemics
por: Park, Jong-Hyeon
Publicado: (2013)

Application of Heparin Affinity Chromatography to Produce a Differential Vaccine without Eliciting Antibodies against the Nonstructural Proteins of the Serotype O Foot-and-Mouth Disease Viruses
por: Park, Sun Young, et al.
Publicado: (2020)

The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine
por: Ko, Mi-Kyeong, et al.
Publicado: (2023)

Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses
por: Lee, Min Ja, et al.
Publicado: (2020)

The Potential Adjuvanticity of CAvant(®)SOE for Foot-and-Mouth Disease Vaccine
por: Ahn, Young-Hoon, et al.
Publicado: (2021)

Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5
por: Kim, Hyejin, et al.
Publicado: (2021)

Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs
por: Hwang, Ji-Hyeon, et al.
Publicado: (2019)

Control of type O foot-and-mouth disease by vaccination in Korea, 2014–2015
por: Park, Jong-Hyeon, et al.
Publicado: (2018)

Reemergence of Foot-and-Mouth Disease, South Korea, 2000–2011
por: Park, Jong-Hyeon, et al.
Publicado: (2014)

Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs
por: Choi, Joo-Hyung, et al.
Publicado: (2020)

Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease
por: Choi, Joo-Hyung, et al.
Publicado: (2018)

Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents
por: Kim, Su-Mi, et al.
Publicado: (2012)

Novel foot-and-mouth disease virus in Korea, July-August 2014
por: Park, Jong-Hyeon, et al.
Publicado: (2016)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

Efficacy of a Novel Multiepitope Vaccine Candidate against Foot-and-Mouth Disease Virus Serotype O and A
por: Chathuranga, W. A. Gayan, et al.
Publicado: (2022)

Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs
por: Shin, Sehee, et al.
Publicado: (2022)

Recombinant vesicular stomatitis virus glycoprotein carrying a foot-and-mouth disease virus epitope as a vaccine candidate
por: LEE, Hyang-Sim, et al.
Publicado: (2020)

Evaluation of Vaccine Strains Developed for Efficient, Broad-Range Protection against Foot-and-Mouth Disease Type O
por: Hwang, Seong Yun, et al.
Publicado: (2023)

Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice
por: Bae, Ji-young, et al.
Publicado: (2009)

Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease
por: Liu, D., et al.
Publicado: (2019)

Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs
por: Jo, Hye-Eun, et al.
Publicado: (2019)

Author Correction: Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants
por: Shin, Yura, et al.
Publicado: (2022)

Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea
por: KIM, Ah-Young, et al.
Publicado: (2017)

The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity
por: Lee, Min Ja, et al.
Publicado: (2022)

Supplementation of dietary germanium biotite enhances induction of the immune responses by foot-and-mouth disease vaccine in cattle
por: Jung, Myunghwan, et al.
Publicado: (2014)

Control of Foot-and-Mouth Disease during 2010–2011 Epidemic, South Korea
por: Park, Jong-Hyeon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_593jcvkinhj13n7m9qrqfpig8r